Everest Medicines Ltd
HKEX:1952
Wall Street
Price Targets
Price Targets Summary
Everest Medicines Ltd
According to Wall Street analysts, the average 1-year price target for Everest Medicines Ltd is 25.45 HKD with a low forecast of 23.58 HKD and a high forecast of 28.35 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Everest Medicines Ltd's stock price target?
Price Target
25.45
HKD
According to Wall Street analysts, the average 1-year price target for Everest Medicines Ltd is 25.45 HKD with a low forecast of 23.58 HKD and a high forecast of 28.35 HKD.
What is Everest Medicines Ltd's Revenue forecast?
Projected CAGR
157%
The compound annual growth rate of Everest Medicines Ltd's revenue for the next 3 years is 157%.